Sign In
Buy BLPH
$0.0120
+0 (+0%)
At Close: Mar 17, 2025
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 18)
ADC Therapeutics SA (NYSE:...
Bellerophon Therapeutics Announces Proposed Public Offering of Common Stock
08:03pm, Monday, 18'th May 2020
All of the shares in the offering are to be sold by Bellerophon. Bellerophon also intends to grant the underwriters a 30-day option to purchase up to an additional fifteen percent (15%) of the number
Bellerophon Provides Clinical Program Update and Reports First Quarter 2020 Financial Results
08:01pm, Monday, 11'th May 2020
WARREN, N.J., May 11, 2020 -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH), (“Bellerophon” or the “Company”) a clinical-stage biotherapeutics company focused on developing.
WARREN, N.J., May 11, 2020 -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company focused on developing.
Bellerophon Therapeutics to Participate in COVID-19 Panel at Maxim Group’s Infectious Disease Virtual Conference
12:30pm, Monday, 04'th May 2020
WARREN, N.J., May 04, 2020 -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary.
Stocks To Watch: Jobs Report, Virtual Conferences And Blue Chips On Tap
01:09pm, Saturday, 02'nd May 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th
LVS, INO among premarket gainers
01:21pm, Thursday, 23'rd Apr 2020
CounterPath (NASDAQ:CPAH) +91% on Q4 update.Borqs Technologies (NASDAQ:BRQS) +22% on launching mobile smart tracking cloud solution.Immunomedics (NASDAQ:IMMU) +34% as FDA gave approval to its trea
20 Healthcare Stocks Moving In Thursday's Pre-Market Session
11:31am, Thursday, 23'rd Apr 2020
Gainers
• Immunomedics, Inc. (NASDAQ:IMMU) stock rose 31.29% to $28.87 during Thursday's pre-market session. The most recent rating by H.C. Wainwright, on Apr 23, is at...
These experimental drugs may help keep COVID-19 patients off ventilators
04:19pm, Friday, 17'th Apr 2020
Several experimental therapies being tested as treatments for COVID-19 patients who are severely ill with COVID-19 aim to reduce reliance on mechanical...
ROKU, CCL among premarket gainers today
01:20pm, Tuesday, 14'th Apr 2020
Sonnet BioTherapeutics Holdings (NASDAQ:SONN) +100%.MEI Pharma (NASDAQ:MEIP) +71% on license deal for blood cancer candidate.NantKwest (NASDAQ:NK) +39% being with ImmunityBio on active discussion
31 Stocks Moving in Tuesday's Pre-Market Session
11:10am, Tuesday, 14'th Apr 2020
Gainers
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares rose 66% to $8.20 in pre-market trading.
Tiziana Life Sciences PLC (NASDAQ: TLSA) shares rose 44.8% to $4.46...
Piper Sandler softens view on Cronos Group in premarket analyst action
11:08am, Tuesday, 14'th Apr 2020
Axsome Therapeutics (NASDAQ:AXSM) initiated with an Outperform rating and a $95 (58% upside) price target at Cowen and Company.Bellerophon Therapeutics (NASDAQ:BLPH) initiated with a Buy rating at Bro
Covid-19: Could Bellerphon Therapeutics’ INOpulse Help Address Hospital Ventilator Shortage?
12:23am, Thursday, 09'th Apr 2020
Last year, according to the World Economic Forum, 77,000 new ventilators were enough to meet the market demand worldwide. For context, this month alone, New York City predicts a need for an extra 30,0
